Oric Pharmaceuticals, Inc.ORIC
Price (close)
$13.18
Market cap
$1.4B
P/E
—
Revenue (TTM)
—
Net income
-$140.4M
Dividend yield
—
1-year total return
26.6%
Net margin
—
Revenue growth
—
Debt / equity
—
What Oric Pharmaceuticals, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | -$73.7M | -$78.7M | -$89.1M | -$100.7M | -$127.8M | -$129.5M |
| Free cash flow | -$45.9M | -$60.5M | -$77.2M | -$86.5M | -$113.8M | -$111.7M |
More on ORIC.
- Oric Pharmaceuticals, Inc. summary
- Oric Pharmaceuticals, Inc. financial statements
- Oric Pharmaceuticals, Inc. key metrics
- Oric Pharmaceuticals, Inc. health scores and style box
- Oric Pharmaceuticals, Inc. earnings
- Oric Pharmaceuticals, Inc. dividends
- Oric Pharmaceuticals, Inc. valuation
- Oric Pharmaceuticals, Inc. ownership and insiders
- Oric Pharmaceuticals, Inc. peers
Figures from Oric Pharmaceuticals, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.